Ventripoint Diagnostics Ltd. (TSXV:VPT)
Canada · Delayed Price · Currency is CAD 0.1100
+0.0050 (4.76%)
Jul 24, 2026, 9:33 AM EST
Ventripoint Diagnostics Market Cap
Ventripoint Diagnostics has a market cap or net worth of CAD 20.06 million as of July 24, 2026. Its market cap has decreased by -17.14% in one year.
Market Cap
20.06M
Enterprise Value
22.61M
Revenue
179.93K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
ChartMarket Cap Chart
Since September 21, 2007, Ventripoint Diagnostics's market cap has increased from 6.82M to 20.06M, an increase of 193.88%. That is a compound annual growth rate of 5.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 20.06M | -14.86% |
| Dec 31, 2025 | 23.56M | 45.40% |
| Dec 31, 2024 | 16.20M | -64.98% |
| Dec 29, 2023 | 46.26M | 9.26% |
| Dec 30, 2022 | 42.34M | -21.10% |
| Dec 31, 2021 | 53.67M | 567.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theralase Technologies | 76.87M |
| Cannabix Technologies | 68.79M |
| Perimeter Medical Imaging AI | 49.10M |
| Cheelcare | 35.83M |
| Conavi Medical | 20.70M |
| MedX Health | 18.04M |
| Aurora Spine | 17.43M |
| VVT Med | 16.70M |